# Jerini

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jerini

- Industry: Pharmaceuticals
- Headquarters: Berlin, Germany
- Total disclosed funding: $58M
- Latest round: Series B (Feb 15, 2005)
- Investors on record: 10

## About

Jerini AG was a Germany-based biopharmaceutical and biotechnology company headquartered in Berlin, Germany. Founded in 1994, the company specialized in the discovery and development of peptide-based therapeutics for diseases with limited or inadequate treatment options. Jerini developed a proprietary Peptides-to-Drugs (P2D) technology platform used to identify and optimize novel drug candidates.

## Funding rounds

- Series B, Feb 15, 2005, $20M — 3i, HealthCap, TVM Capital Life Science, NGN Capital, IBB Ventures, Bioscience Investment Trust PLC
- Series B, Jun 9, 2004, $38M — 3i, HealthCap, TVM Capital Life Science, PolyTechnos Venture-Partners, BMP, Houston Ventures, IBB Ventures
- Series A, Jun 1, 2001 — CMP Capital Management-Partners

## Investors

- CMP Capital Management-Partners (https://capitalatlas.ai/funds/cmp-capital-management-partners) — Series A
- 3i (https://capitalatlas.ai/funds/3i) — Series B
- HealthCap — Series B
- TVM Capital Life Science (https://capitalatlas.ai/funds/tvm-capital-life-science) — Series B
- PolyTechnos Venture-Partners (https://capitalatlas.ai/funds/polytechnos-venture-partners) — Series B
- BMP (https://capitalatlas.ai/funds/bmp) — Series B
- Houston Ventures (https://capitalatlas.ai/funds/houston-ventures) — Series B
- IBB Ventures (https://capitalatlas.ai/funds/ibb-ventures) — Series B
- NGN Capital (https://capitalatlas.ai/funds/ngn-capital) — Series B
- Bioscience Investment Trust PLC — Series B